These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 18804138

  • 1. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S, Rüssmann H, Kamanova J, Sebo P, Sturm A, Heussler V, Fleischer B, Jacobs T.
    Vaccine; 2008 Nov 05; 26(47):5935-43. PubMed ID: 18804138
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Nematode-induced interference with the anti-Plasmodium CD8+ T-cell response can be overcome by optimizing antigen administration.
    Kolbaum J, Tartz S, Hartmann W, Helm S, Nagel A, Heussler V, Sebo P, Fleischer B, Jacobs T, Breloer M.
    Eur J Immunol; 2012 Apr 05; 42(4):890-900. PubMed ID: 22161305
    [Abstract] [Full Text] [Related]

  • 5. A strong CD8+ T cell response is elicited using the synthetic polypeptide from the C-terminus of the circumsporozoite protein of Plasmodium berghei together with the adjuvant QS-21: quantitative and phenotypic comparison with the vaccine model of irradiated sporozoites.
    Meraldi V, Romero JF, Kensil C, Corradin G.
    Vaccine; 2005 Apr 15; 23(21):2801-12. PubMed ID: 15780728
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL, Snyder HL, Krzych U.
    J Immunol; 1996 May 01; 156(9):3374-81. PubMed ID: 8617963
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. CD8+ T cell adjuvant effects of Salmonella FliCd flagellin in live vaccine vectors or as purified protein.
    Braga CJ, Massis LM, Sbrogio-Almeida ME, Alencar BC, Bargieri DY, Boscardin SB, Rodrigues MM, Ferreira LC.
    Vaccine; 2010 Feb 03; 28(5):1373-82. PubMed ID: 19932669
    [Abstract] [Full Text] [Related]

  • 10. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A.
    Walsh DS, Gettayacamin M, Leitner WW, Lyon JA, Stewart VA, Marit G, Pichyangkul S, Gosi P, Tongtawe P, Kester KE, Holland CA, Kolodny N, Cohen J, Voss G, Ballou WR, Heppner DG.
    Vaccine; 2006 May 08; 24(19):4167-78. PubMed ID: 16574282
    [Abstract] [Full Text] [Related]

  • 11. Progress in DNA-based heterologous prime-boost immunization strategies for malaria.
    Moore AC, Hill AV.
    Immunol Rev; 2004 Jun 08; 199():126-43. PubMed ID: 15233731
    [Abstract] [Full Text] [Related]

  • 12. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL, Doolan DL.
    Dev Biol (Basel); 2000 Jun 08; 104():121-32. PubMed ID: 11713810
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys.
    Rodríguez A, Mintardjo R, Tax D, Gillissen G, Custers J, Pau MG, Klap J, Santra S, Balachandran H, Letvin NL, Goudsmit J, Radosević K.
    Vaccine; 2009 Oct 19; 27(44):6226-33. PubMed ID: 19686691
    [Abstract] [Full Text] [Related]

  • 14. An increase in antimycobacterial Th1-cell responses by prime-boost protocols of immunization does not enhance protection against tuberculosis.
    Majlessi L, Simsova M, Jarvis Z, Brodin P, Rojas MJ, Bauche C, Nouzé C, Ladant D, Cole ST, Sebo P, Leclerc C.
    Infect Immun; 2006 Apr 19; 74(4):2128-37. PubMed ID: 16552042
    [Abstract] [Full Text] [Related]

  • 15. Single-dose immunogenicity and protective efficacy of simian adenoviral vectors against Plasmodium berghei.
    Reyes-Sandoval A, Sridhar S, Berthoud T, Moore AC, Harty JT, Gilbert SC, Gao G, Ertl HC, Wilson JC, Hill AV.
    Eur J Immunol; 2008 Mar 19; 38(3):732-41. PubMed ID: 18266272
    [Abstract] [Full Text] [Related]

  • 16. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.
    J Immunol; 2009 Nov 01; 183(9):5870-8. PubMed ID: 19812194
    [Abstract] [Full Text] [Related]

  • 17. Processing of the circumsporozoite protein in infected hepatocytes is not dependent on aspartic proteases.
    Bongfen SE, Balam S, Torgler R, Romero JF, Corradin G.
    Parasite Immunol; 2008 Nov 01; 30(6-7):375-8. PubMed ID: 18444957
    [Abstract] [Full Text] [Related]

  • 18. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
    Leitner WW, Seguin MC, Ballou WR, Seitz JP, Schultz AM, Sheehy MJ, Lyon JA.
    J Immunol; 1997 Dec 15; 159(12):6112-9. PubMed ID: 9550412
    [Abstract] [Full Text] [Related]

  • 19. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L, Fayolle C, Bauche C, Ladant D, Leclerc C.
    J Virol; 2005 Aug 15; 79(15):9872-84. PubMed ID: 16014948
    [Abstract] [Full Text] [Related]

  • 20. Cloned cytotoxic T cells recognize an epitope in the circumsporozoite protein and protect against malaria.
    Romero P, Maryanski JL, Corradin G, Nussenzweig RS, Nussenzweig V, Zavala F.
    Nature; 1989 Sep 28; 341(6240):323-6. PubMed ID: 2477703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.